Finance

Lists
Why is 300562 down 2,46%?
Dive Deeper
300562:SHE
Guangdong Transtek Medicl Elctrncs CoLtd
13,08 CN¥
-2,46%
(-0,33) 1D
16-окт., 15:04:58 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300562...
Open
13,67 CN¥
High
13,77 CN¥
Low
12,94 CN¥
Mkt. cap
2,94 млд
Avg. vol.
16,51 млн
Volume
8,14 млн
Dividend
1,99%
Quarterly dividend
0,07 CN¥
Ex-dividend date
2026-ж., 15-окт.
P/E ratio
28,64
52-wk high
19,54 CN¥
52-wk low
11,32 CN¥
EPS
0,46 CN¥
Shares outstanding
218,93 млн
No. of employees
1 миң
Open
13,67 CN¥
High
13,77 CN¥
Low
12,94 CN¥
Mkt. cap
2,94 млд
Avg. vol.
16,51 млн
Volume
8,14 млн
Dividend
1,99%
Quarterly dividend
0,07 CN¥
Ex-dividend date
2026-ж., 15-окт.
P/E ratio
28,64
52-wk high
19,54 CN¥
52-wk low
11,32 CN¥
EPS
0,46 CN¥
Shares outstanding
218,93 млн
No. of employees
1 миң
News stories
From web sources and news partners
Profile
Transtek Medical, commonly known as Lifesense, fully referred to as Guangdong Transtek Medical Electronics Co., Ltd., is a Chinese wearable device maker that also focuses on the field of mobile health. The company was founded by Weichao Pan in 2002, with its main products being home medical and health electronics, such as scales, smart bracelets and blood pressure monitors. According to IDC, the company shipped one million units of wearables in the second quarter of 2016, ranking fifth in the global wearable devices market, coming in behind Fitbit, Apple and Garmin. Transtek's IPO application was approved by the CSRC in October 2016. On November 16, it landed on the Shenzhen Stock Exchange with the ticker symbol "300562.SZ". Wikipedia
About Guangdong Transtek Medicl Elctrncs CoLtd
CEO-
Employees1,09 миң
Founded2002-ж., 18-июл.
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
235,76 млн
229,08 млн
283,74 млн
250,69 млн
Cost of goods sold
149,14 млн
152,94 млн
176,58 млн
166,11 млн
Cost of revenue
149,14 млн
152,94 млн
176,58 млн
166,11 млн
Research and development expenses
20,36 млн
24,79 млн
26,69 млн
23,33 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41,57 млн
26,45 млн
41,12 млн
21,85 млн
Operating expense
58,96 млн
52,61 млн
71,19 млн
48,25 млн
Total operating expenses
208,10 млн
205,55 млн
247,78 млн
214,35 млн
Operating income
27,66 млн
23,53 млн
35,96 млн
36,34 млн
Other non operating income
-3,39 млн
2,22 млн
-4,58 млн
3,96 млн
EBT including unusual items
23,63 млн
16,59 млн
32,82 млн
31,28 млн
EBT excluding unusual items
25,70 млн
24,73 млн
31,68 млн
34,21 млн
Income tax expense
118,51 миң
1,08 млн
931,10 миң
3,84 млн
Effective tax rate
0,50%
6,54%
2,84%
12,27%
Other operating expenses
-1,92 млн
3,87 млн
1,19 млн
2,80 млн
Net income
23,39 млн
16,32 млн
32,07 млн
27,96 млн
Net profit margin
9,92%
7,12%
11,30%
11,15%
Earnings per share
-
-
-
-
Interest and investment income
3,39 млн
2,85 млн
330,33 миң
3,10 млн
Interest expense
-1,40 млн
-
-37,02 миң
-57,71 миң
Net interest expenses
1,99 млн
2,85 млн
293,32 миң
3,05 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
32,45 млн
28,29 млн
40,73 млн
41,00 млн
Gain or loss from assets sale
-150,13 миң
26,11 миң
-
-1,36 млн
AI content may include mistakes. Learn more
Google колдонмолору